Attached files

file filename
EX-10.3 - EX-10.3 - ALVOGEN ROW AMENDMENT 3 - Pfenex Inc.pfnx-ex103_105.htm
EX-31.1 - EX-31.1 - Pfenex Inc.pfnx-ex311_7.htm
EX-10.4 - EX-10.4 - ALVOGEN US AMENDMENT 2 - Pfenex Inc.pfnx-ex104_104.htm
EX-10.2 - EX-10.2 DEED OF ASSIGNMENT - Pfenex Inc.pfnx-ex102_12.htm
10-Q - 10-Q - Pfenex Inc.pfnx-10q_20200630.htm

 

Exhibit 32.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Evert B. Schimmelpennink, certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, that the Quarterly Report of Pfenex Inc. on Form 10-Q for the quarterly period ended June 30, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Pfenex Inc.

 

August 6, 2020

 

/s/ Evert B. Schimmelpennink

Evert B. Schimmelpennink

Chief Executive Officer, President and Secretary, and Chief Financial Officer

(Principal Executive Officer and Principal Financial   and Accounting Officer)